21-44305863-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_001002021.3(PFKL):c.163C>T(p.Arg55*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0429 in 1,366,024 control chromosomes in the GnomAD database, including 1,515 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.032 ( 140 hom., cov: 33)
Exomes 𝑓: 0.044 ( 1375 hom. )
Consequence
PFKL
NM_001002021.3 stop_gained
NM_001002021.3 stop_gained
Scores
1
1
Clinical Significance
Conservation
PhyloP100: 0.286
Genes affected
PFKL (HGNC:8876): (phosphofructokinase, liver type) This gene encodes the liver (L) subunit of an enzyme that catalyzes the conversion of D-fructose 6-phosphate to D-fructose 1,6-bisphosphate, which is a key step in glucose metabolism (glycolysis). This enzyme is a tetramer that may be composed of different subunits encoded by distinct genes in different tissues. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant 21-44305863-C-T is Benign according to our data. Variant chr21-44305863-C-T is described in ClinVar as [Benign]. Clinvar id is 3059937.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0323 (4917/152216) while in subpopulation NFE AF= 0.0485 (3294/67980). AF 95% confidence interval is 0.0471. There are 140 homozygotes in gnomad4. There are 2237 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 140 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PFKL | NM_002626.6 | c.86-818C>T | intron_variant | ENST00000349048.9 | NP_002617.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PFKL | ENST00000349048.9 | c.86-818C>T | intron_variant | 1 | NM_002626.6 | ENSP00000269848.6 |
Frequencies
GnomAD3 genomes AF: 0.0323 AC: 4918AN: 152098Hom.: 140 Cov.: 33
GnomAD3 genomes
AF:
AC:
4918
AN:
152098
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0319 AC: 7890AN: 247646Hom.: 172 AF XY: 0.0326 AC XY: 4374AN XY: 134298
GnomAD3 exomes
AF:
AC:
7890
AN:
247646
Hom.:
AF XY:
AC XY:
4374
AN XY:
134298
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0442 AC: 53685AN: 1213808Hom.: 1375 Cov.: 33 AF XY: 0.0436 AC XY: 26199AN XY: 601366
GnomAD4 exome
AF:
AC:
53685
AN:
1213808
Hom.:
Cov.:
33
AF XY:
AC XY:
26199
AN XY:
601366
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0323 AC: 4917AN: 152216Hom.: 140 Cov.: 33 AF XY: 0.0301 AC XY: 2237AN XY: 74414
GnomAD4 genome
AF:
AC:
4917
AN:
152216
Hom.:
Cov.:
33
AF XY:
AC XY:
2237
AN XY:
74414
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
30
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
PFKL-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 05, 2020 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at